Clinical Trial Update: Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

This clinical trial update summarizes the Phase 3 results of MM-398 (liposomal irinotecan) with or without 5-FU/leucovorin versus 5-FU/leucovorin alone in metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil/Leucovorin (5-FU/leucovorin)
• MM-398 (liposomal irinotecan) (liposomal irinotecan)

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Metastatic Pancreatic Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-02-12